drugset / Trial / NCT00733356

The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading

NCT00733356

Phase 4 Completed 42 enrolled Kimberley Lakes Shire · collab
NaSingle-groupSingle-blindBasic science

Summary

This is a single-blind, Investigator Initiated study to evaluate the safety and efficacy of Vyvanse™ and provide pilot data in two areas: (1) on the use of Near-Infrared Spectroscopy to detect medication effects in children with ADHD; and (2) on the influence of Vyvanse ™ on reading fluency and comprehension, over a period of approximately 6-8 weeks. Subjects will be between the ages of 6 and 12 at the beginning of the study.

Timeline

Start
2008-07
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Dimesylate Small molecule 30 mg
Subject Lisdexamfetamine Dimesylate Small molecule 50 mg
Subject Lisdexamfetamine Dimesylate Small molecule 70 mg